Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Effects of LCI699 on Cortisol in Patients With Hypertension

NCT00817414 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00817414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00817414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Effects of LCI699 on Cortisol in Patients With Hypertension
Lead sponsor
Novartis
Phase
Phase 2
Overall status
Completed
Start date
January 14, 2009
Completion date
August 12, 2009
Enrollment
63 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension